Shilpa Medicare Q2 FY26 Financial Results: Reports 144% Net Profit Growth & Significant Margin Expansion

Shilpa Medicare Ltd. announced strong financial results for the second quarter of Fiscal Year 2026 (ended September 30, 2025), demonstrating significant growth in profitability and operational efficiency. The company's performance was highlighted by a 144% year-on-year (YoY) surge in consolidated net profit, which climbed to ₹44 crore from ₹18 crore in the corresponding quarter of the previous fiscal year. Key Financial Highlights (Q2 FY26 vs. Q2 FY25): Net Profit: Recorded a 144% YoY increase to ₹44 crore. Revenue from Operations: Grew by 7.6% YoY to ₹370 crore, compared to ₹344 crore. EBITDA: Showed robust 26% YoY growth, reaching ₹108.8 crore from ₹86.2 crore. Operating (EBITDA) Margin: Witnessed a significant expansion of 440 basis points, improving to 29.4% from 25% in the prior-year period. Analysis for Investors: The quarterly performance indicates strong bottom-line growth that significantly outpaced top-line revenue growth. This was driven by a substantial improvement in operational efficiency, as reflected in the 26% rise in EBITDA and the notable expansion of the operating margin to 29.4%. This performance underscores the company's ability to enhance profitability through higher margins. Market Data (November 13, 2025): Following the announcement, the shares of Shilpa Medicare Ltd closed at ₹387.10 on the BSE, down 3.14% (₹12.55) for the session.